Waksal, who is not a medical doctor, imported the veterinary drug along with other “unapproved ingredients” from Colombia.

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

MAIA Biotechnology, Inc.’s MAIA share price has dipped by 6.67%, which has investors questioning if this is right time to buy ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

Oncolytics Biotech Inc.’s ONCY share price has dipped by 5.04%, which has investors questioning if this is right time to buy.

India has developed indigenously built HPV diagnostic kits for screening of cervical cancer, which are affordable methods for ...

After exposure to measles, you should postpone your cancer care appointments until you know you haven’t developed it. If you ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Bay Area biotech company Tempest Therapeutics was once valued at more than $1 billion, but now it's running out of gas. Last week, the cancer researcher revealed plans to lay off all but five of its ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor ...

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.